Inactive Instrument
Epirus Biopharmaceuticals Inc Stock Nasdaq
Stocks
US29428P1075
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 746K 647K 610K 554K 1.04M 71.53M 1.05M 7.29M 2.81M 36.28M 2.8M 2.74M 115M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -13.81M -13.03M -11.82M -22.18M -1.53B -22.34M -156M -59.97M -775M -59.85M -58.53M -2.46B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| 1 day | -25.00% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -25.00% | -.--% | - | - | 26 | |
| -0.43% | -4.42% | -2.89% | +6.84% | 45.63B | |
| +0.66% | -2.34% | +340.62% | +530.14% | 43.96B | |
| +1.49% | -0.78% | +41.90% | +24.75% | 43.73B | |
| +2.11% | -1.24% | +9.09% | +78.25% | 40.23B | |
| +0.34% | -4.03% | +9.34% | +38.90% | 31.86B | |
| +0.53% | -2.08% | - | - | 17.4B | |
| +1.34% | +0.70% | +21.35% | +112.62% | 16.62B | |
| +0.72% | +2.19% | +15.35% | +31.43% | 14.46B | |
| -1.85% | -5.33% | +78.63% | +31.45% | 13.04B | |
| Average | -1.99% | -1.73% | +64.18% | +106.80% | 29.66B | |
| Weighted average by Cap. | +0.72% | -2.01% | +75.91% | +127.54% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.19 0.02 0.01 0.62 | 0.7 0.61 0.57 0.52 0.98 67.19 0.98 6.85 2.64 34.08 2.63 2.57 108.36 |
| Net income | -41.84M -36.26M -34.22M -31.04M -58.23M -4.01B -58.65M -409M -157M -2.03B -157M -154M -6.47B | -52.19M -45.22M -42.68M -38.72M -72.63M -5B -73.15M -510M -196M -2.54B -196M -192M -8.07B |
| Net Debt | -14.18M -12.29M -11.6M -10.52M -19.73M -1.36B -19.88M -138M -53.36M -689M -53.26M -52.08M -2.19B | -16.68M -14.45M -13.64M -12.38M -23.22M -1.6B -23.38M -163M -62.78M -811M -62.66M -61.27M -2.58B |
Employees
-
